CS
ZVSAW

Clear Street’s ZyVersa Therapeutics, Inc. Warrants ZVSAW Stock Holding History

Clear Street’s Portfolio ZVSAW Stock Details ZVSAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-156,238
Closed -$19K – 1517
2022
Q3 		$19K Buy
156,238
+9,411
+6% +$1.22K ﹤0.01% 499
2022
Q2 		$16K Buy
+146,827
New +$25.5K ﹤0.01% 462

Clear Street's ZVSAW Position: Q4 2022 in Review

Clear Street sold out of ZyVersa Therapeutics, Inc. Warrants (ZVSAW) in Q4 2022, closing a stake of 156,238 shares — an estimated $19K sold.

Clear Street first reported a position in ZVSAW in Q2 2022 and held it in 2 quarters. The position peaked at $19K in Q3 2022. 1 fund tracked by Wall St. Rank holds ZVSAW as of Q4 2022.

  • Clear Street reported no remaining ZyVersa Therapeutics, Inc. Warrants position as of Q4 2022 after selling out during the quarter.
  • Clear Street sold 156,238 ZyVersa Therapeutics, Inc. Warrants shares in Q4 2022, an estimated $19K.
  • Clear Street first reported a position in ZyVersa Therapeutics, Inc. Warrants in Q2 2022 and held it in 2 quarters.
  • Clear Street's ZyVersa Therapeutics, Inc. Warrants position peaked at $19K in Q3 2022.
  • 1 fund tracked by Wall St. Rank held ZyVersa Therapeutics, Inc. Warrants as of Q4 2022.

Based on Clear Street's 13F filing for Q4 2022, filed 13 Feb 2023.